Log in to save to my catalogue

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1...

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fa4414bc3272439a9714929ad02b2689

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway

About this item

Full title

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway

Publisher

England: BioMed Central Ltd

Journal title

BMC medicine, 2021-11, Vol.19 (1), p.283-283, Article 283

Language

English

Formats

Publication information

Publisher

England: BioMed Central Ltd

More information

Scope and Contents

Contents

Chimeric antigen receptor T (CAR-T) cell therapy has limited effects in the treatment of solid tumors. Sulforaphane (SFN) is known to play an important role in inhibiting tumor growth, but its effect on CAR-T cells remains unclear. The goal of the current study was to determine whether combined CAR-T cells and SFN could provide antitumor efficacy a...

Alternative Titles

Full title

Sulforaphane enhances the antitumor response of chimeric antigen receptor T cells by regulating PD-1/PD-L1 pathway

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fa4414bc3272439a9714929ad02b2689

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fa4414bc3272439a9714929ad02b2689

Other Identifiers

ISSN

1741-7015

E-ISSN

1741-7015

DOI

10.1186/s12916-021-02161-8

How to access this item